Evaluation of drug-specific multigene markers to predict aromatase inhibitor efficacy in advanced breast cancer: a cohort study from Danish Breast Cancer …

IK Buhl, TD Christensen, ASK Buhl, IJ Christensen… - 2019 - researchsquare.com
Background Even with positive oestrogen receptor (ER+) status some advanced breast
cancer (ABC) patients fail to benefit from endocrine therapy (ET). A method that previously …